biostudies-literatureFaridar AAlzheimer&apos;s AssociationAlzheimer's Association54https://www.ebi.ac.uk/biostudies/studies/S-EPMC10652426biostudies-literatureUnknown12(1)<h4>Trial registration</h4>ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.<h4>Clinicaltrials</h4>gov/ct2/show/NCT05821153.Translational neurodegenerationA phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.PMC10652426PTCG-21-1818034Roman GCThome ADPascual MBGrundman MZhao WAppel SHDavis CSMasdeu JCBeers DRNakawah MOFaridar AEid AMfalseA phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.<h4>Trial registration</h4>ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.<h4>Clinicaltrials</h4>gov/ct2/show/NCT05821153.2023-01-01T00:00:00Z2023 Nov2026-07-14T19:25:28.549Z2024-10-19T11:20:59.921ZS-EPMC106524263796871810.1186/s40035-023-00387-5